Logo image of AKRX

Akorn Inc (AKRX) Stock Price, Quote, News and Overview

NASDAQ:AKRX - Nasdaq -

0.09  -0.09 (-51.01%)

After market: 0.1299 +0.04 (+44.33%)

AKRX Quote, Performance and Key Statistics

Akorn Inc

NASDAQ:AKRX (5/29/2020, 8:01:22 PM)

After market: 0.1299 +0.04 (+44.33%)

0.09

-0.09 (-51.01%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High5.46
52 Week Low0.09
Market Cap11.98M
Shares133.15M
Float96.26M
Yearly DividendN/A
Dividend YieldN/A
PE0.64
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


AKRX short term performance overview.The bars show the price performance of AKRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

AKRX long term performance overview.The bars show the price performance of AKRX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AKRX is 0.09 null. In the past month the price decreased by -57.14%. In the past year, price decreased by -97.82%.

Akorn Inc / AKRX Daily stock chart

About AKRX

Company Profile

Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. Akorn markets its products to retail pharmacies, ophthalmologists, optometrists, physicians, veterinarians, hospitals, clinics, wholesalers, distributors, group purchasing organizations, and government agencies. Their strategy is focused on continuing to strengthen our leadership position in the development and marketing of specialized generic and branded pharmaceuticals, over-the-counter (`OTC`) drug products and animal health products.

Company Info

Akorn Inc

1925 WEST FIELD COURT SUITE 300

LAKE FOREST IL 60045

CEO: Douglas S. Boothe

Phone: 847-279-6100

Akorn Inc / AKRX FAQ

What is the stock price of Akorn Inc today?

The current stock price of AKRX is 0.09 null. The price decreased by -51.01% in the last trading session.


What is the ticker symbol for Akorn Inc stock?

The exchange symbol of Akorn Inc is AKRX and it is listed on the Nasdaq exchange.


On which exchange is AKRX stock listed?

AKRX stock is listed on the Nasdaq exchange.


What is Akorn Inc worth?

Akorn Inc (AKRX) has a market capitalization of 11.98M null. This makes AKRX a Nano Cap stock.


Should I buy Akorn Inc (AKRX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Akorn Inc (AKRX) stock pay dividends?

AKRX does not pay a dividend.


What is the Price/Earnings (PE) ratio of Akorn Inc (AKRX)?

The PE ratio for Akorn Inc (AKRX) is 0.64. This is based on the reported non-GAAP earnings per share of 0.14 and the current share price of 0.09 null. Check the full fundamental report for a full analysis of the valuation metrics for AKRX.


AKRX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AKRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to AKRX. While AKRX is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKRX Financial Highlights

Over the last trailing twelve months AKRX reported a non-GAAP Earnings per Share(EPS) of 0.14000000000000004. The EPS increased by 122.58% compared to the year before.


Industry RankSector Rank
PM (TTM) -55.64%
ROA -38.88%
ROE N/A
Debt/Equity -1.1
Chartmill High Growth Momentum
EPS Q2Q%342.86%
Sales Q2Q%23.4%
EPS 1Y (TTM)122.58%
Revenue 1Y (TTM)6.72%

AKRX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to AKRX. The Buy consensus is the average rating of analysts ratings from 1 analysts.


Ownership
Inst Owners0%
Ins Owners2.7%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y-2.94%
Revenue Next YearN/A